Antiviral Therapy Improves Survival After Liver Cancer Surgery - Liver Cancer HEAD TOPICS
Antiviral Therapy Improves Survival After Liver Cancer Surgery
10/22/2022 4:09:00 AM A preprint study takes a first look at how antiviral therapies impact OS of elderly patients after hepatectomy for Hep B and HCC
Hepatocellular Carcinoma Liver Cancer
Source Medscape
A preprint study takes a first look at how antiviral therapies impact OS of elderly patients after hepatectomy for Hep B and HCC . The analysis focused on elderly patients after hepatectomy for hepatitis B virus–related hepatocellular carcinoma . The study was published as a preprint and has not yet been peer review ed. Results were not correlated with HBV genotype or use of specific antiviral therapy drugs.DisclosuresThe study was funded by the Medical Innovation Project of Fujian Province and others.The investigators have disclosed no relevant financial relationships. This is a summary of a preprint research study,"The Efficacy of Postoperative Antiviral Therapy in Elderly HCC Patients: A Retrospective Multicenter Propensity Score-Matched Study," led by Jinyu Zhang of the Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China, and provided to you by Medscape. The study has not been peer reviewed. The full text can be found at Read more:
Medscape » Targeted Cancer Therapy: Recent Developments in Targeted Cancer Treatment, Cancer Genetic and Epigenetic Changes, Ten Hallmarks of Cancer Long-term preservation of liver grafts brings ‘off-the-shelf’ organs closer - Nature Biotechnology Scientists found a molecule that destroys even the worst cancers in mice Have You Ever Lied to Your Therapist? Coach s Corner Tennessee Offensive Coordinator Alex Golesh
Clint Cosgrove is joined this week by Tennessee Offensive Coordinator Alex Golesh to discuss the Volunteers' hot start to the season and their exciting victo... Read more >> Targeted Cancer Therapy: Recent Developments in Targeted Cancer Treatment, Cancer Genetic and Epigenetic Changes, Ten Hallmarks of CancerGenetic and epigenetic mechanisms initiate the progression of cancer. Therapeutic approaches to cancer include local control with surgery and/or radiation, with combination chemotherapy for systemic control. Long-term preservation of liver grafts brings ‘off-the-shelf’ organs closer - Nature BiotechnologyNature Biotechnology - Long-term preservation of liver grafts brings ‘off-the-shelf’ organs closer Scientists found a molecule that destroys even the worst cancers in miceScientists have discovered a new molecular cancer treatment that eradicates even the worst cancers in mice. Not sure how this relates to the “worst cancers” (whatever that means) since it did not work on one of two cancer types on which it was tested. But it is very promising for certain solid tumors that are vulnerable to immunotherapy but are “protected” from it. Have You Ever Lied to Your Therapist?Here’s why eating and body image problems are so often avoided or lied about in the therapy room, by TherapistAlli Prepping for the Apocalypse Means Building Community“These sorts of things aren't something you can outrun,” says anthropologist and survival instructor Chris Begley. It was a retrospective study limited to patients in China.Cells lacking hTERT have a diminished capacity for DNA double-break repair.1 , who described the successful 1-year post-liver-transplant (LT) outcome of a patient who received a liver graft after 3 days of normothermic perfusion.October 20th, 2022 at 3:20 PM By Joshua Hawkins Scientists working at Yale and the University of Rhode Island (URI) have discovered a new molecular cancer treatment that can home in on cancer cells and eradicate tumors in mice. Results were not correlated with HBV genotype or use of specific antiviral therapy drugs. Disclosures The study was funded by the Medical Innovation Project of Fujian Province and others. Another approach of targeting telomeres is the G-quadruplex with ligands such as RHPS4. The investigators have disclosed no relevant financial relationships. This is a summary of a preprint research study,"The Efficacy of Postoperative Antiviral Therapy in Elderly HCC Patients: A Retrospective Multicenter Propensity Score-Matched Study," led by Jinyu Zhang of the Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China, and provided to you by Medscape. Limitless replication potential is also due to aberrant cell cycle control in tumor cells, which are driven by overexpression of cell cycle (CDKs), checkpoint (CHKs) mitotic kinases, and abnormal DNA damage repair responses. The study has not been peer reviewed. These fire up the tumors, allowing the immune system to respond to them. The full text can be found at researchsquare. CDK inhibitors Advances in cell cycle regulatory mechanisms over the last 10 years has illustrated the importance of aberrations in key players that contribute to cancer pathogenesis.com . M. Progression through major cell cycles is mediated by sequential assembly and activation of a family of S/T kinases, the cyclin-dependent kinases (CDKs). Alexander Otto is a physician assistant with a master's degree in medical science and a journalism degree from Newhouse. He is an award-winning medical journalist who has worked for several major news outlets before joining Medscape and also an MIT Knight Science Journalism fellow. The cyclin family is divided into 2 main classes: G1 cyclins (C, D1-3, E) accumulation is rate limiting for progression from G1 to S phase; mitotic or G2 cyclins (A and B) are involved in the control of G2/M transition and mitosis. Image source: filin174 / Adobe By using the molecule to guide the drug to the tumors and cancer cells, they’re able to kick them out of the “cold” tumor range and push the immune system to fight back. Email: .